50 results
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
and healthy environment for our directors, members of management and stockholders who wish to attend the Annual Meeting. You will be able to attend … business environment, as well as the commitment required to serve as our Chairman, particularly as the board of directors’ oversight responsibilities
8-K
EX-10.1
0i8rl 3zk
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
iftrj bcmjigms5
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-10.1
cxc71 bzwz9f5a8c6
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
5ntp7c7iq9718
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.2
rovw6mfi slkg
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
DEFA14A
tjl9pg654
7 Apr 22
Additional proxy soliciting materials
4:00pm
8-K
EX-10.1
284dftf5 b9brn
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
424B5
3ogsqv
16 Mar 22
Prospectus supplement for primary offering
8:00am